Key Takeaways
- • TA Associates, a U.S. private equity firm, is in active negotiations to acquire Advanced Medical Solutions (AMS), a London-listed British medical supplier specializing in wound-care dressing technologies.
- • Under UK Takeover Code rules, TA Associates must either announce a firm intention to make an offer or withdraw by May 16, 2026, establishing a critical decision deadline for the transaction.
- • No deal terms have been disclosed by AMS as of the announcement date; the valuation and structure of TA Associates' potential offer remain undisclosed.
- • TA Associates' approach reflects a broader wave of overseas private equity activity targeting UK-listed companies, capitalizing on relatively depressed equity valuations in the British market.
- • TA Associates demonstrated prior capability and appetite for UK acquisitions, having completed a $722 million acquisition of FD Technologies, a British data and analytics firm, in the preceding year.
Summary
Advanced Medical Solutions announced on April 20 that it is engaged in negotiations with TA Associates, a U.S.-based private equity firm, regarding a potential takeover of the company. AMS, which develops and supplies wound-care dressing technologies, disclosed the approach in a regulatory announcement, signaling that formal discussions are underway regarding a potential acquisition.
TA Associates' bid represents the latest in a series of acquisition approaches directed at London-listed companies by overseas buyout firms seeking to capitalize on UK equity valuations that remain relatively subdued compared to other developed markets. The timing and nature of this approach align with a visible uptick in cross-border M&A activity targeting British public companies.
The transaction is subject to formal regulatory timelines established by the UK Takeover Code. TA Associates must announce either a firm intention to make an offer or formally withdraw from the process by May 16, 2026. No terms of the potential offer have been disclosed by AMS as of the announcement date, leaving deal valuation and structure undetermined pending further negotiations.
AMS has previously attracted private equity interest from other prominent firms. Bridgepoint, another major private equity investor, has been reported to have shown interest in the company in prior periods, though no transaction materialized. TA Associates has demonstrated active engagement with the UK market, evidenced by its $722 million acquisition of FD Technologies, a British data and analytics firm, completed in the preceding year. This track record suggests the firm possesses both capital capacity and strategic interest in acquiring quality British businesses at the right valuation.
TA Associates' bid represents the latest in a series of acquisition approaches directed at London-listed companies by overseas buyout firms seeking to capitalize on UK equity valuations that remain relatively subdued compared to other developed markets. The timing and nature of this approach align with a visible uptick in cross-border M&A activity targeting British public companies.
The transaction is subject to formal regulatory timelines established by the UK Takeover Code. TA Associates must announce either a firm intention to make an offer or formally withdraw from the process by May 16, 2026. No terms of the potential offer have been disclosed by AMS as of the announcement date, leaving deal valuation and structure undetermined pending further negotiations.
AMS has previously attracted private equity interest from other prominent firms. Bridgepoint, another major private equity investor, has been reported to have shown interest in the company in prior periods, though no transaction materialized. TA Associates has demonstrated active engagement with the UK market, evidenced by its $722 million acquisition of FD Technologies, a British data and analytics firm, completed in the preceding year. This track record suggests the firm possesses both capital capacity and strategic interest in acquiring quality British businesses at the right valuation.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.